• Open an A/C
    • Open an A/C
    • Trading A/c
    • Mutual Fund A/c
    • NBFC A/c
    • NPS A/c

Home > News >

  • Lasa Supergenerics
  • December 13,2017  18:45
  • FY 17 being the first year of operations post demerger, FY 16 financials are not available for comparison.

    For quarter ended Sep 17, net sales stood at Rs 64.53 crore. OPM stood at 20.2% resulting in a OP of Rs 13.03 crore. Other income stood at Rs 1.35 crore. Interest cost and deprecation cost stood at Rs 2.42 crore and Rs 6.09 crore respectively. Due to MAT credit, overall tax credit stood at Rs 2.78 crore and PAT for Sep 17 quarter stood at Rs 8.65 crore.

    For 6 months ended Sep 17, net sales stood at Rs 123.23 crore. OPM stood at 23% resulting in a OP of Rs 28.35 crore. Other income stood at Rs 2.65 crore. Interest cost and deprecation cost stood at Rs 4.96 crore and Rs 8.51 crore respectively. Total Tax stood at Rs 1.84 crore and PAT for H1 ended Sep 17 stood at Rs 15.69 crore.

    Commenting on the quarterly and half yearly unaudited results, Mr. Omkar Herlekar, Chairman & Managing Director, Lasa Supergenerics said:

    This second quarter of financial year FY18, we have registered a revenue growth of 10% and our overall profit has also shown a tremendous increase of over 23%. We are very happy that our consistent performance and focus on new and innovative products has been successfully helping us to bag new orders and grow our business. We have witnessed a lot of demand from different geographies for our products and remain focused on developing advanced catalyst chemistry for our molecules to enhance its productivity.

    Lasa Supergenerics: Results


    Net Sales64.53123.23199.66
    OPM (%)20.2%23.0%22.7%
    Other Income1.352.650.30
    PBT before EO5.8717.5327.60
    PBT after EO5.8717.53-3.01
    EPS (Rs)*##-
    * Annualized on current equity of Rs 22.86 crore. Face Value: Rs 10
    FY 17 is the first year of the company post de-merger hence FY 16 financials are not available
    LP: Loss to Profit PL: Profit to Loss
    EO: Extraordinary items;
    EPS is calculated after excluding EO and relevant tax
    Var.(%) exceeding 999 is restricted to 999
    Figures in crore, Source: Capitaline Database

    Powered by Capital Market - Live News

Follow us:

Disclaimer: Investment in securities and commodities market are subject to market risks, read all the related documents carefully before investing. SMC Global Securities Ltd. (CIN : U67120DL1997PLC188881): NSE INB/ INF/INE 230771431, BSE INB/INF 011343937, MSEI INB/INF 260771432, CDSL/NSDL-IN-DP-130-2015, SMC Research Analyst Registration- INH 100001849 I SMC Comtrade Ltd.: NCDEX/MCX (8200)/ NMCE/ICEX-INZ000035839 I SMC Investments and Advisors Ltd.: PMS INP000003435 I SMC Insurance Brokers Pvt. Ltd., IRDAI Regi: No: DB 272/04, License No. 289 Valid upto 27/01/2020 I Registered Office: 11/6B, Shanti Chamber, Pusa Road, New Delhi-110005, Tel.: (011) 30111000. For any complaints email – igc@smcindiaonline.com, website: www.smctradeonline.com

Insurance is the subject matter of solicitation • All insurance products sold through SMC Insurance Brokers Pvt. Ltd. • Investment Banking Services provided by SMC Capitals Ltd. • Equity PMS and Wealth management services provided by SMC Investments & Advisors Ltd. • IPOs and Mutual Funds distribution services are provided by SMC Global Securities Ltd. • Financing Services provided by Moneywise Financial Services Pvt Ltd. • Commodity broking services provided by SMC Comtrade Ltd. • Real Estate Advisory services are offered through SMC Real Estate Advisors Pvt. Ltd.


Toll-free : 1800-11-0909
Email: contact@smctradeonline.com

Copyright ©2016 SMC. All Rights Reserved | Disclaimer | Privacy Policy | RMS Policy | Copyright| Testimonials| Sitemap| Grievance| design agency: triverse| Powered by C-MOTS Infotech (ISO 9001:2015 certified)
Open An Account

Open my trading account now!  X 

* All fields are compulsory